載入...
US Pharmaceutical Innovation in an International Context
Objectives. We explored whether the United States, which does not regulate pharmaceutical prices, is responsible for the development of a disproportionate share of the new molecular entities (NMEs; a drug that does not contain an active moiety previously approved by the Food and Drug Administration)...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Public Health Association
2010
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2866602/ https://ncbi.nlm.nih.gov/pubmed/20403883 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2105/AJPH.2009.178491 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|